{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:06:57Z","timestamp":1784020017383,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Breast Cancer Research Foundation, United States","award":["BCRF-18-099"],"award-info":[{"award-number":["BCRF-18-099"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10549-026-07970-0","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:04:04Z","timestamp":1776391444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vivo exposure to CXCL12-high CAFs and chronic CXCL12 stimulation in vitro is sufficient to enhance metastasis of ER-positive breast cancer"],"prefix":"10.1007","volume":"217","author":[{"given":"Philip C.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utsav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaXiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsie","family":"Medina-Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Picon-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Morata-Tarifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Bare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Slingerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorraya","family":"El-Ashry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"Lippman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"7970_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1755-8794-5-39","volume":"5","author":"J Tchou","year":"2012","unstructured":"Tchou J, Kossenkov AV, Chang L, Satija C, Herlyn M, Showe LC et al (2012) Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles. BMC Med Genomics 5:39","journal-title":"BMC Med Genomics"},{"issue":"3","key":"7970_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M et al (2018) Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33(3):463\u201379 e10","journal-title":"Cancer Cell"},{"key":"7970_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s43018-020-0082-y","volume":"1","author":"G Friedman","year":"2020","unstructured":"Friedman G, Levi-Galibov O, David E, Bornstein C, Giladi A, Dadiani M et al (2020) Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome. Nature Cancer 1:692","journal-title":"Nature Cancer"},{"issue":"5","key":"7970_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6(5):392\u2013401","journal-title":"Nat Rev Cancer"},{"key":"7970_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16:582","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"7970_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H et al (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6(1):17\u201332","journal-title":"Cancer Cell"},{"issue":"2","key":"7970_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18(2):99\u2013115","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"7970_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10549-014-2887-9","volume":"144","author":"K Drews-Elger","year":"2014","unstructured":"Drews-Elger K, Brinkman JA, Miller P, Shah SH, Harrell JC, da Silva TG et al (2014) Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures. Breast Cancer Res Treat 144(3):503\u2013517","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"7970_CR9","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1080\/15384047.2015.1071742","volume":"16","author":"SH Shah","year":"2015","unstructured":"Shah SH, Miller P, Garcia-Contreras M, Ao Z, Machlin L, Issa E et al (2015) Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype. Cancer Biol Ther 16(11):1671\u20131681","journal-title":"Cancer Biol Ther"},{"issue":"14","key":"7970_CR10","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W et al (2016) FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res 76(14):4124\u20134135","journal-title":"Cancer Res"},{"issue":"14","key":"7970_CR11","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1002\/cam4.2523","volume":"8","author":"T Aizawa","year":"2019","unstructured":"Aizawa T, Karasawa H, Funayama R, Shirota M, Suzuki T, Maeda S et al (2019) Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer. Cancer Med 8(14):6370\u20136382","journal-title":"Cancer Med"},{"issue":"3","key":"7970_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.18632\/oncotarget.1169","volume":"5","author":"MP Ablett","year":"2014","unstructured":"Ablett MP, O\u2019Brien CS, Sims AH, Farnie G, Clarke RB (2014) A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity. Oncotarget 5(3):599\u2013612","journal-title":"Oncotarget"},{"issue":"5","key":"7970_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1210\/me.2002-0438","volume":"17","author":"JM Hall","year":"2003","unstructured":"Hall JM, Korach KS (2003) Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 17(5):792\u2013803","journal-title":"Mol Endocrinol"},{"key":"7970_CR14","first-page":"1347","volume":"6","author":"M Cojoc","year":"2013","unstructured":"Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A (2013) Emerging targets in cancer management: role of the CXCL12\/CXCR4 axis. Onco Targets Ther 6:1347\u20131361","journal-title":"Onco Targets Ther"},{"issue":"9","key":"7970_CR15","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A et al (2021) A single-cell and spatially resolved atlas of human breast cancers. Nat Genet 53(9):1334\u20131347","journal-title":"Nat Genet"},{"key":"7970_CR16","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612","journal-title":"Nat Commun"},{"issue":"7403","key":"7970_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ et al (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403):346\u2013352","journal-title":"Nature"},{"issue":"1","key":"7970_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2005.06.021","volume":"238","author":"KE Luker","year":"2006","unstructured":"Luker KE, Luker GD (2006) Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238(1):30\u201341","journal-title":"Cancer Lett"},{"issue":"11","key":"7970_CR19","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2174\/138161210791034012","volume":"16","author":"AC Hirbe","year":"2010","unstructured":"Hirbe AC, Morgan EA, Weilbaecher KN (2010) The CXCR4\/SDF-1 chemokine axis: a potential therapeutic target for bone metastases? Curr Pharm Des 16(11):1284\u20131290","journal-title":"Curr Pharm Des"},{"issue":"6","key":"7970_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.biopha.2006.06.004","volume":"60","author":"MZ Dewan","year":"2006","unstructured":"Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M, Yamamoto N (2006) Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 60(6):273\u2013276","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"7970_CR21","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1158\/0008-5472.CAN-08-4924","volume":"69","author":"K Sauve","year":"2009","unstructured":"Sauve K, Lepage J, Sanchez M, Heveker N, Tremblay A (2009) Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway. Cancer Res 69(14):5793\u20135800","journal-title":"Cancer Res"},{"issue":"3","key":"7970_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121(3):335\u2013348","journal-title":"Cell"},{"issue":"15","key":"7970_CR23","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.4161\/cc.5.15.3112","volume":"5","author":"A Orimo","year":"2006","unstructured":"Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 5(15):1597\u20131601","journal-title":"Cell Cycle"},{"issue":"3","key":"7970_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/bjc.2013.768","volume":"110","author":"Y Yu","year":"2014","unstructured":"Yu Y, Xiao CH, Tan LD, Wang QS, Li XQ, Feng YM (2014) Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. Br J Cancer 110(3):724\u2013732","journal-title":"Br J Cancer"},{"issue":"2","key":"7970_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1158\/1078-0432.CCR-14-2053","volume":"21","author":"PC Miller","year":"2015","unstructured":"Miller PC, Clarke J, Koru-Sengul T, Brinkman J, El-Ashry D (2015) A novel MAPK-microRNA signature is predictive of hormone-therapy resistance and poor outcome in ER-positive breast cancer. Clin Cancer Res 21(2):373\u2013385","journal-title":"Clin Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07970-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07970-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07970-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:30:09Z","timestamp":1784017809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07970-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7970"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07970-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.M. discloses that at he is presently employed full-time by Natera, Inc. and may hold stock or stock options. This relationship is unrelated to the subject matter of the present study, and Natera had no role in the study design, data collection, analysis, interpretation, or manuscript preparation. No other authors declare any financial or non-financial conflicts of interest related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"21"}}